Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.71 |
| ▸ | MEN1 | O00255 | 3/20 | 0.71 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.71 |
| ▸ | MAPT | P10636 | 2/20 | 0.71 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.71 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.71 |
| ▸ | LMNA | P02545 | 3/20 | 0.65 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.53 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.53 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.51 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.49 |
| ▸ | PTPRF | P10586 | 1/20 | 0.49 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.49 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL7965212 | 0.98 | MEN1 (0.69) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| Hydrochloric Acid SCHEMBL11134565 | 0.98 | ALDH1A1 (0.74) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| SCHEMBL9505752 | 0.89 | ALDH1A1 (0.63) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| SCHEMBL9241499 | 0.87 | MEN1 (0.60) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| Bromide SCHEMBL8664123 | 0.84 | MEN1 (0.94) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| Hydrochloric Acid SCHEMBL11134568 | 0.84 | ALDH1A1 (0.79) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| SCHEMBL8733835 | 0.81 | ALDH1A1 (0.50) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| Bromide SCHEMBL11681833 | 0.81 | KMT2A (0.56) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| Iodide SCHEMBL29278144 | 0.81 | LMNA (0.64) | ALDH1A1MEN1KMT2AMAPTKDM4E | |
| Bromide SCHEMBL28605769 | 0.81 | ALDH1A1 (0.61) | ALDH1A1MEN1KMT2AMAPTKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0385504-B1 | Heat-latent curing catalyst and resin compositions containing the same | NIPPON PAINT CO LTD (JP) | 1995-10-04 | — | — | EP | claimed |
| CN-115160213-B | Rheum emodic acid pyridine quaternary ammonium salt compound and synthetic method and application thereof | 丽江师范高等专科学校 | 2024-02-13 | — | — | CN | disclosed |
| US-20160228356-A1 | THE CONTINUOUS LONG-TERM CONTROLLED RELEASE OF TELOMERASE INHIBITORS | LASTER, Brenda (IL) | 2016-08-11 | — | — | US | disclosed |
| CN-1246412-C | Adhesive for flexible printed circuit board | TAIHONG SCIENCE & TECHNOLOGY C (CN) | 2006-03-22 | — | — | CN | disclosed |
| CN-1407049-A | Adhesive for flexible printed circuit board | TAIHONG SCIENCE & TECHNOLOGY C (CN) | 2003-04-02 | — | — | CN | disclosed |
| EP-0543022-B1 | PROCESS FOR PRODUCING STYRENIC POLYMER AND CATALYST THEREFOR | IDEMITSU KOSAN CO (JP) | 1998-02-04 | — | — | EP | disclosed |
| US-5391661-A | Process for producing a styrenic polymer and a catalyst for use therein | IDEMITSU KOSAN CO., LTD. (JP) | 1995-02-21 | — | — | US | disclosed |
| EP-0543022-A1 | PROCESS FOR PRODUCING STYRENIC POLYMER AND CATALYST THEREFOR | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-05-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160228356-A1 | THE CONTINUOUS LONG-TERM CONTROLLED RELEASE OF TELOMERASE INHIBITORS | TERT, POT1, TERF2 | ALDH1A1 1296/4885MEN1 895/4885KMT2A 2366/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.